Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
Author(s) -
S. Hescot,
María Currás-Freixes,
Timo Deutschbein,
Anouk van Berkel,
Delphine Vezzosi,
Laurence Amar,
Christelle de la Fouchardière,
Nuria Valdés,
Ferdinando Riccardi,
Christine Do Cao,
Jérôme Bertherat,
B. Goichot,
Felix Beuschlein,
D. Drui,
Letizia Canu,
Patricia Niccoli,
S. Laboureau,
Antoine Tabarin,
Sophie Leboulleux,
Bruna Calsina,
Rossella Libé,
Antongiulio Faggiano,
Martin Schlumberger,
Françoise BorsonChazot,
Massimo Mannelli,
AnnePaule GimenezRoqueplo,
Philippe Caron,
Henri Timmers,
Martin Faßnacht,
Mercedes Robledo,
Isabelle Borget,
Éric Baudin
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01968
Subject(s) - paraganglioma , sdhb , medicine , pheochromocytoma , univariate analysis , malignancy , metanephrines , retrospective cohort study , hazard ratio , oncology , pathology , gastroenterology , multivariate analysis , biology , confidence interval , germline mutation , biochemistry , mutation , gene
Malignant pheochromocytoma and paraganglioma (MPP) are characterized by prognostic heterogeneity. Our objective was to look for prognostic parameters of overall survival (OS) in MPP patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom